Neuroone Medical Technologies CorpNASDAQ:NMTC
- LAST PRICE0.9299
- TODAY'S CHANGE (%)-0.0152 (-1.6083%)
- Bid / Lots0.9300/ 8
- Ask / Lots0.9900/ 12
- Open / Previous Close0.9300 / 0.9451
- Day Range
- 52 Week Range
- Volume73,708
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NMTC |
|---|---|---|
| 09:32 ET | 10020 | 0.95 |
| 09:34 ET | 1490 | 0.9201 |
| 09:41 ET | 2000 | 0.9662 |
| 09:43 ET | 1800 | 0.966 |
| 09:48 ET | 100 | 0.966 |
| 09:54 ET | 100 | 0.92 |
| 10:01 ET | 100 | 0.9369 |
| 10:06 ET | 250 | 0.94 |
| 10:10 ET | 250 | 0.94 |
| 10:17 ET | 100 | 0.98 |
| 10:21 ET | 100 | 0.95 |
| 10:24 ET | 400 | 0.94 |
| 10:42 ET | 100 | 0.98 |
| 10:55 ET | 101 | 0.960001 |
| 11:06 ET | 2187 | 0.96 |
| 11:09 ET | 19389 | 0.9405 |
| 11:11 ET | 396 | 0.95 |
| 11:44 ET | 100 | 0.94 |
| 11:45 ET | 1000 | 0.920101 |
| 11:47 ET | 130 | 0.921 |
| 12:00 ET | 1186 | 0.96 |
| 12:05 ET | 500 | 0.920001 |
| 12:07 ET | 1500 | 0.9599 |
| 12:14 ET | 100 | 0.96 |
| 12:23 ET | 100 | 0.95999 |
| 12:52 ET | 100 | 0.94 |
| 01:01 ET | 100 | 0.96 |
| 01:10 ET | 325 | 0.927 |
| 01:28 ET | 100 | 0.96 |
| 01:53 ET | 100 | 0.96 |
| 01:55 ET | 965 | 0.94005 |
| 02:00 ET | 800 | 0.9202 |
| 02:08 ET | 10333 | 0.92 |
| 02:24 ET | 325 | 0.95 |
| 02:26 ET | 100 | 0.96 |
| 02:42 ET | 1000 | 0.9599 |
| 02:44 ET | 100 | 0.95 |
| 03:02 ET | 150 | 0.959658 |
| 03:30 ET | 400 | 0.95 |
| 03:39 ET | 100 | 0.95 |
| 03:41 ET | 200 | 0.95 |
| 03:52 ET | 100 | 0.95 |
| 03:59 ET | 200 | 0.9299 |
May 14, 2024
NeuroOne(R) Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update, from 4:00PM ET on Tuesday May 14, 2024 by Dow Jones
4:00PM ET on Tuesday May 14, 2024 by Dow JonesNeuroOne(R) Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update, from 4:00PM ET on Tuesday May 14, 2024 by Dow Jones
4:00PM ET on Tuesday May 14, 2024 by Dow Jones
May 10, 2024
NeuroOne(R) to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14, from 2:43PM ET on Friday May 10, 2024 by Dow Jones
2:43PM ET on Friday May 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Neuroone Medical Technologies Corp | 25.6M | -1.6x | --- |
Renalytix PLC | 32.4M | -0.5x | --- |
Positron Corp | 29.8M | -12.8x | --- |
Akili Inc | 33.1M | -0.7x | --- |
PAVmed Inc | 13.7M | -0.2x | --- |
ADM Tronics Unlimited Inc | 5.3M | -7.5x | --- |
Company Information
NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. The Company is focused on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure and artificial intelligence. Its Evo cortical electrode technology records, monitors, and stimulates brain tissue on the surface of the brain. Its products include strip/grid, depth electrodes (sEEG Products) and electrode cable assembly products.
Contact Information
- Headquarters
- 7599 Anagram DrEDEN PRAIRIE, MN, United States 55344-7399
- Phone
- 952-426-1383
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Paul Buckman
- President, Chief Executive Officer, Director
- David Rosa
- Co-Founder, Business Development Director - Medical Sales Liaison
- Mark Christianson
- Chief Financial Officer
- Ronald Mcclurg
- Chief Operating Officer
- Christopher Volker
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $25.6M |
|---|---|
Revenue (TTM) | $3.8M |
Shares Outstanding | 27.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.98 |
EPS | $-0.59 |
Book Value | $0.26 |
P/E Ratio | -1.6x |
Price/Sales (TTM) | 6.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -343.78% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
